Clinical Trial Update: DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402

View source ↗

Summary

An update on the completed ECOG-E4402 study reports on DNA analyses to identify biomarkers that influence response to rituximab in patients with follicular lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Status: COMPLETED